Skip to content
  1. EMEA Innovative Medicine /
  2. VOKANAMET (canagliflozin) receives positive CHMP Opinion in the EU

VOKANAMET (canagliflozin) receives positive CHMP Opinion in the EU

VOKANAMET (canagliflozin and metformin fixed dose combination) receives positive CHMP opinion recommending approval in the European Union for the treatment of adults with type 2 diabetes